Analgesic activity of new ligands of the NMDA receptor complex

Abstract

BACKGROUND: The activation of spinal cord NMDA receptors is a key factor in the pathogenesis of acute and chronic pain. Therefore, the use of existing NMDA antagonists in analgesic schemes and the development of new compounds targeting the NMDA receptor complex are gaining attention. New ligands of the glutamate NMDA receptor complex are derivatives of imidazole-4,5-dicarboxylic acid. The conformational rigidity of the molecules of imidazole-4,5-dicarboxylic acid derivatives allows for increased selectivity of interaction and reduced side effects.

AIM: This study aimed to investigate the analgesic effect of new ligands of the glutamate NMDA receptor complex, which are derivatives of imidazole-4,5-dicarboxylic acid, in rats using the tail-flick test and the formalin test.

MATERIALS AND METHODS: The analgesic activity of the compounds was examined in a model of acute somatic (thermal) pain in the tail-flick test and model of somatic pain induced by algogens in the formalin test. The tested compounds (IEM-303 and IEM-2044) were administered intraperitoneally at doses of 5, 10, 15, and 20 mg/kg. Мetamizole was used as the comparison drug.

RESULTS: The experiments demonstrated a significant dose-dependent analgesic effect of the tested compounds on the experimental models of acute pain at doses of 5–20 mg/kg. The tail-flick latency increased by 1.4–1.7 times in the IEM-2044 and IEM-303 groups compared with the value in the control group.

CONCLUSIONS: The analgesic activity of the tested compounds at 10–20 mg/kg doses was comparable to that of metamizole, indicating the prospect of developing these agents and further searching for effective and safe analgesics in this pharmacological class.

Keywords

glutamate / NMDA receptor antagonists / imidazole-4,5-dicarboxylic acid derivatives / analgesic effect / mice

References

[1] Song X-J, Zhao Z-Q. Cooperative interaction among the various regulatory sites within the NMDA receptor-channel complex in modulating the evoked responses to noxious thermal stimuli ot spinal dorsal horn neurons in the cat. Exp Bram Res. 1998;120:257–262. doi: 10.1007/s002210050399

[2] Song X.-J., Zhao Z.-Q. Cooperative interaction among the various regulatory sites within the NMDA receptor-channel complex in modulating the evoked responses to noxious thermal stimuli ot spinal dorsal horn neurons in the cat // Exp Bram Res. 1998. Vol. 120. P. 257–262. doi: 10.1007/s002210050399

[3] Wolkerstorfer A, Handler N, Buschmann H. Hand-book of pain assessment. Turk D, Melzack R, editors. 3rd ed. New York: Guilford Press; 2011. 542 p.

[4] Wolkerstorfer A., Handler N., Buschmann H. Hand-book of pain assessment / D. Turk, R. Melzack, editors. 3rd ed. New York: Guilford Press, 2011. 542 p.

[5] Behbehani MM, Fields HL. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res. 1979;170(1):85–93. doi: 10.1016/0006-8993(79)90942-9

[6] Behbehani M.M., Fields H.L. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia // Brain Res. 1979. Vol. 170, N 1. P. 85–93. doi: 10.1016/0006-8993(79)90942-9

[7] Dickenson AH, Chapman V, Green GM. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol: Vascular Syst. 1997;28(5):633–638. doi: 10.1016/S0306-3623(96)00359-X

[8] Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord // Gen Pharmacol: Vascular Syst. 1997. Vol. 28, N 5. P. 633–638. doi: 10.1016/S0306-3623(96)00359-X

[9] Wolkerstorfer A, Handler N, Buschmann H. New approaches to treating pain. Bioorg Med Chem Lett. 2016;26(4):1103–1119. doi: 10.1016/j.bmcl.2015.12.103

[10] Wolkerstorfer A., Handler N., Buschmann H. New approaches to treating pain // Bioorg Med Chem Lett. 2016. Vol. 26, N 4. P. 1103–1119. doi: 10.1016/j.bmcl.2015.12.103

[11] Piotrovsky LB, Lishko PV, Maksymyuk AP, et al. A new class of agonists and antagonists of N-methyl-D-aspartic acid receptors — derivatives of imidazole-4,5- and pyrazole-3,4-dicarboxylic acids. Russian journal of physiology. 1999;85(4):523–530. (In Russ.)

[12] Piotrovsky L.B., Lishko P.V., Maksimjuk A.P. A new class of NMDA receptor agonists and antagonists are imidazole-4,5- and pyrazole-3,4-dicarboxylic acid derivatives // Российский физиологический журнал им. И.М. Сеченова. 1999. Т. 85, № 4. С. 523–530.

[13] Dougherty PM, Willis WD. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain. 1991;47(1):85–93. doi: 10.1016/0304-3959(91)90015-P

[14] Dougherty P.M., Willis W.D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P // Pain. 1991. Vol. 47, N 1. P. 85–93. doi: 10.1016/0304-3959(91)90015-P

[15] Davydova ON, Boldyre AA Glutamate receptors in neuronal and immune system cells. Annals of Clinical and Experimental Neurology. 2007;1(4):28–34. EDN: MTCWGX

[16] Давыдова О.Н., Болдырев А.А. Глутаматные рецепторы в клетках нервной и иммунной систем // Анналы клинической и экспериментальной неврологии. 2007. Т. 1, № 4. С. 28–34. EDN: MTCWGX

[17] Alyautdin RN. Pharmacology. Moscow: GEOTAR-Media, 2019. 352 p. (In Russ.)

[18] Аляутдин Р.Н. Фармакология. Москва: ГЭОТАР-Медиа, 2019. 352 с.

[19] Yakovleva EE, Bychkov ER, Brusina MM, Piotrovsky LB, Shabanov PD. Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression ttests in mice and rats. Res Results in Pharmacol. 2020;6(4):51–57. doi: 10.3897/rrpharmacology.6.57883.

[20] Yakovleva EE, Bychkov ER, Brusina MM, Piotrovsky LB, Shabanov PD. Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression tests in mice and rats // Res Results in Pharmacol. 2020. Vol. 6, N 4. P. 51–57. doi: 10.3897/rrpharmacology.6.57883

[21] Bespalov AY, Zvartau EE. Neuropsychopharmacology of NMDA-receptor antagonists. Saint Petersburg: Nevsky Dialect; 2000. 297 p. (In Russ.)

[22] Беспалов А.Ю., Звартау Э.Э. Нейропсихофармакология антагонистов NMDA-рецепторов. Санкт-Петербург: Невский диалект, 2000. 297 с.

[23] Mironov AN, Bunatyan ND. Guidelines for conducting preclinical studies of medicines. Part one. Mironov NA, editor. Moscow: Grif and K; 2013. (In Russ.)

[24] Миронов А.Н., Бунатян Н.Д. Руководство по проведению доклинических исследований лекарственных средств. Часть первая / под ред. А.Н. Миронова. Москва: Гриф и К, 2013.

[25] Olivar Т, Laird JM. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain. 1999;79(1):67–73. doi: 10.1016/S0304-3959(98)00152-3

[26] Olivar Т., Laird J.M. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes // Pain. 1999. Vol. 79, N 1. P. 67–73. doi: 10.1016/S0304-3959(98)00152-3

[27] Lutfy K, Cai SX, Woodward RM, et al. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 1997;70(1):31–40. doi: 10.1016/S0304-3959(96)03290-3

[28] Lutfy K., Cai S.X., Woodward R.M., et al. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice // Pain. 1997. Vol. 70, N 1. P. 31–40. doi: 10.1016/S0304-3959(96)03290-3

[29] Jeftinija S. Excitatory transmission in the dorsal horn is in part mediated through APV-sensitive NMDA receptors. Neurosci Lett. 1989;96(2):191–196. doi: 10.1016/0304-3940(89)90056-6

[30] Jeftinija S. Excitatory transmission in the dorsal horn is in part mediated through APV-sensitive NMDA receptors // Neurosci Lett. 1989. Vol. 96, N 2. P. 191–196. doi: 10.1016/0304-3940(89)90056-6

[31] Raigorodsky G, Urca G. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate. Eur J Pharmacol. 1990;182(1):37–47. doi: 10.1016/0014-2999(90)90491-N

[32] Raigorodsky G., Urca G. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate // Eur J Pharmacol. 1990. Vol. 182, N 1. P. 37–47. doi: 10.1016/0014-2999(90)90491-N

[33] Yaksh TL, Hua X-Y, Kalcheva I, et al. The spinal biology in humans and animals of pain states generated by persistent small afferent input. PNAS. 1999;96(14):7680–7686. doi: 10.1073/pnas.96.14.7680

[34] Yaksh T.L., Hua X.-Y., Kalcheva I., et al. The spinal biology in humans and animals of pain states generated by persistent small afferent input // PNAS. 1999. Vol. 96, N 14. P. 7680–7686. doi: 10.1073/pnas.96.14.7680

[35] McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. PNAS USA. 2007;104(33):13525–13530. doi: 10.1073/pnas.0705924104

[36] McNamara C.R., Mandel-Brehm J., Bautista D.M., et al. TRPA1 mediates formalin-induced pain // PNAS USA. 2007. Vol. 104, N 33. P. 13525–13530. doi: 10.1073/pnas.0705924104

RIGHTS & PERMISSIONS

ECO-vector LLC